How Neuralink works: brain-computer interfaces and what they can do

01What Neuralink is and how it works

Neuralink Corp. is an American neurotechnology company that is developing implantable brain-computer interfaces (BCIs). It was founded by Elon Musk and a team of eight scientists and engineers. Neuralink was launched in 2016 and first publicly reported in March 2017. The company is based in Fremont,

Neuralink is a neurotechnology company developing implantable brain-computer interfaces. The core product, the N1 implant, is a coin-sized device placed inside the skull that connects to 1,024 ultra-thin electrode threads, each about 5 micrometers wide. Each thread carries multiple electrodes that detect the electrical activity of individual neurons.

The system is designed to be wireless once implanted. It charges inductively through the skin, transmits data via Bluetooth to an external device, and is controlled by a custom application that decodes neural signals in real time. The entire chain, from neuron firing to cursor movement, is intended to operate with minimal latency so the user experiences direct intent translated into action.

02The brain-computer interface technology

A brain–computer interface (BCI), sometimes called a brain–machine interface (BMI), is a direct communication link between the brain's electrical activity and an external device, most commonly a computer or robotic limb. BCIs are often directed at researching, mapping, assisting, augmenting, or repa

A brain-computer interface, or BCI, creates a direct communication pathway between the brain and an external device. Unlike traditional input methods that depend on muscles, a BCI reads neural activity and translates it into commands. Neuralink is one of several approaches, but it is notable for the density of its electrode array and the ambition of its surgical automation.

The BCI field encompasses both invasive and non-invasive systems. Invasive implants like Neuralink place electrodes directly in brain tissue, achieving higher signal resolution but requiring surgery. Non-invasive systems such as EEG caps sit on the scalp, are safe but lower fidelity. The trade-off between signal quality and surgical risk is the central design tension in the field.

03How electrodes read brain signals

Neurons communicate through electrochemical signals called action potentials. When a neuron fires, it generates a brief electrical spike that nearby electrodes can detect. Neuralink threads are inserted into the motor cortex, the region of the brain that plans and controls voluntary movement. Each thread has multiple electrode contacts that listen to the firing patterns of surrounding neurons.

The implant amplifies and digitizes these signals, then transmits them to a decoder algorithm running on an external computer. The decoder learns to map patterns of neural firing to intended actions. For example, when a paralyzed patient imagines moving their hand, the motor cortex produces activity patterns similar to those of an able-bodied person actually moving. The decoder translates that imagined movement into a cursor or robot arm command.

Calibration is an ongoing process. The decoder adapts as it collects more data, and the brain itself changes as the patient learns to use the implant. This co-adaptation between biological tissue and machine learning is what makes BCI both powerful and difficult to stabilize over long periods.

04What patients can control with Neuralink

The first Neuralink trial participant, Noland Arbaugh, was paralyzed from the neck down following a spinal cord injury. After receiving the implant in January 2024, he was able to control a computer cursor, play chess, browse the web, and post on social media using only his thoughts. The performance reached several bits per second on cursor control benchmarks, approaching the level of able-bodied users on some tasks.

Beyond cursor control, BCI technology aims to restore communication for patients with conditions like ALS or locked-in syndrome. A decoder can predict intended text from neural activity, allowing patients to type messages or control speech synthesis devices. Future applications include controlling robotic prosthetics, wheelchairs, and smart home devices, giving paralyzed individuals greater independence.

05The surgical implantation process

Neuralink designed a surgical robot, the R1, to insert the electrode threads with precision that exceeds human manual capability. The robot uses a needle finer than a human hair to place each thread into the brain at a specific depth, avoiding blood vessels to minimize tissue damage. The procedure is intended to be performed in under an hour with minimal incision.

Neuroprosthetics is a discipline related to neuroscience and biomedical engineering concerned with developing neural prostheses. They are sometimes contrasted with a brain–computer interface, which connects the brain to a computer rather than a devic

The surgery begins with a small craniotomy, a circular opening in the skull. The R1 robot then inserts dozens of threads into the cortex. Once the electrodes are in place, the N1 implant is seated into the craniotomy so it sits flush with the skull. The skin is closed over the implant, leaving no visible hardware on the outside. The entire procedure is designed to be outpatient or require only a short hospital stay.

06The risks and complications

Brain surgery carries inherent risks: infection, bleeding, and damage to functional tissue. Beyond the surgery itself, implanted electrodes can cause gliosis, a process where the immune system forms scar tissue around the foreign material. This scar tissue can degrade signal quality over time as neurons near the electrodes are walled off, reducing the implant effectiveness.

In the first Neuralink trial, some electrode threads retracted from their original positions in the weeks after surgery, reducing the number of active channels. The company implemented a software workaround to compensate, but the hardware issue highlights the challenge of maintaining stable electrode-brain interfaces in living tissue that shifts, swells, and remodels.

07What the future of BCI looks like

The near-term goal is expanding clinical trials to more patients and demonstrating reliable control over multiple applications. Neuralink has received FDA approval for its Precision Study, enrolling patients with quadriplegia. Success will depend on whether the implant maintains signal quality over months and years, not just weeks.

Longer-term visions include restoring vision through cortical implants that stimulate the visual cortex, treating neurological conditions like Parkinson disease and epilepsy through closed-loop stimulation, and eventually enabling bidirectional communication where the implant both reads and writes neural signals. The most ambitious goal is general-purpose brain augmentation, but that remains speculative and raises serious ethical questions about privacy, autonomy, and cognitive enhancement.

The regulatory landscape will shape how quickly these technologies reach patients. The FDA requires extensive safety data for implantable neurodevices, and each new indication, whether motor control, communication, or vision, requires separate clinical evidence. The path from first-in-human trials to widely available therapy is measured in years, not months.